Clinical Trial Update: Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial is comparing topical crisaborole 2% with tacrolimus 0.1% in children with mild-to-moderate atopic dermatitis. The study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)
• Protopic (tacrolimus)

Snippet

Sponsor: Shalamar Institute of Health Sciences | Conditions: Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 3 | Status: NOT_YET_RECRUITING